{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:11:50Z","timestamp":1788142310426,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ajog.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T12:46:00Z","timestamp":1499517960000},"page":"88-97.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Drug interactions between non-rifamycin antibiotics and hormonal contraception: a\u00a0systematic review"],"prefix":"10.1016","volume":"218","author":[{"given":"Katharine B.","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.07.003_bib1","unstructured":"Trends in contraceptive use worldwide. In: Department of Economic and Social Affairs PD, ed. New York: United Nations;\u00a02015."},{"key":"10.1016\/j.ajog.2017.07.003_bib2","first-page":"853","article-title":"Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.07.003_bib3","unstructured":"Guidance for industry: Drug interaction studies - study design, data analysis, implications for dosing, and labeling recommendations. In: Food and Drug Administration, ed. 2012. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM292362.pdf. Accessed June 7, 2017."},{"key":"10.1016\/j.ajog.2017.07.003_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4321\/S1886-36552009000300002","article-title":"Survey of pharmacists and physicians on drug interactions between combined oral contraceptives and broad-spectrum antibiotics","volume":"7","author":"Masters","year":"2009","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.ajog.2017.07.003_bib5","unstructured":"Medical Eligibility Criteria for Contraceptive Use: World Health Organization, 2015. Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/MEC-5\/en\/. Accessed May 18, 2017."},{"key":"10.1016\/j.ajog.2017.07.003_bib6","unstructured":"United States medical eligibility criteria for contraceptive use, 2016. MMWR Morb Mortal Wkly Rep 65;3:1-103."},{"key":"10.1016\/j.ajog.2017.07.003_bib7","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2017.07.003_bib8","unstructured":"US Preventative Services Task Force. Grade definitions. 2016. Available at: https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/grade-definitions#grade-definitions-after-may-2007. Accessed June 7, 2017."},{"key":"10.1016\/j.ajog.2017.07.003_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2016.07.011","article-title":"Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib10","first-page":"924","article-title":"Effect of chemotherapy agents and antibiotics on hormonal contraception [German]","volume":"72","author":"Hempel","year":"1978","journal-title":"Z\u00a0Arztl Fortbild"},{"key":"10.1016\/j.ajog.2017.07.003_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(97)80322-2","article-title":"Oral contraceptive failure rates and oral antibiotics","volume":"36","author":"Helms","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.ajog.2017.07.003_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.contraception.2009.02.013","article-title":"The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General practice research database","volume":"80","author":"Jick","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2010.08.020","article-title":"Antibiotics and oral contraceptive failure: a case-crossover study","volume":"83","author":"Toh","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/pds.3267","article-title":"Are antibiotics related to oral combination contraceptive failures in the Netherlands? A case-crossover study","volume":"21","author":"Koopmans","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2017.07.003_bib15","first-page":"33","article-title":"The effect of ampicillin on oral contraceptive effectiveness","volume":"55","author":"Friedman","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.07.003_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2125.1982.tb04932.x","article-title":"The effects of ampicillin on oral contraceptive steroids in women","volume":"14","author":"Back","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2017.07.003_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0010-7824(80)90089-X","article-title":"A\u00a0study of interaction of low-dose combination oral contraceptive with ampicillin and metronidazole","volume":"22","author":"Joshi","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0022-4731(84)90208-5","article-title":"Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones","volume":"20","author":"Adlercreutz","year":"1984","journal-title":"J\u00a0Steroid Biochem"},{"key":"10.1016\/j.ajog.2017.07.003_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/00016347909154918","article-title":"Plasma and urine levels produced by an oral dose of ampicillin 0.5 G administered to women taking oral contraceptives","volume":"58","author":"Philipson","year":"1979","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2017.07.003_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/1.suppl_3.47","article-title":"Two aspects of the availability of cephalosporins after intramuscular injection","volume":"1","author":"Wise","year":"1975","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2017.07.003_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(91)90617-Z","article-title":"The effect of tetracyclines on levels of oral contraceptives","volume":"164","author":"Murphy","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.07.003_bib22","first-page":"416","article-title":"The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone","volume":"77","author":"Neely","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.07.003_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2165\/00003495-199300453-00102","article-title":"Lack of influence of ciprofloxacin on the effectiveness of oral contraceptives","volume":"46","author":"Droppert","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ajog.2017.07.003_bib24","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1128\/AAC.42.12.3266","article-title":"No interaction between ciprofloxacin and an oral contraceptive","volume":"42","author":"Scholten","year":"1998","journal-title":"Antimicrob Agent Chemother"},{"key":"10.1016\/j.ajog.2017.07.003_bib25","first-page":"451","article-title":"The effect of ciprofloxacin on oral contraceptive steroid treatments","volume":"17","author":"Maggiolo","year":"1991","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ajog.2017.07.003_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01849631","article-title":"Risk for ovulation in women taking a low-dose oral contraceptive (microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin)","volume":"12","author":"Csemiczky","year":"1996","journal-title":"Adv Contracept"},{"key":"10.1016\/j.ajog.2017.07.003_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0010-7824(91)90070-V","article-title":"The lack of interaction between temafloxacin and combined oral contraceptive steroids","volume":"43","author":"Back","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00044011-200121040-00006","article-title":"Effect of hormonal contraceptives on the pharmacokinetics of trovafloxacin in women","volume":"21","author":"Amsden","year":"2001","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ajog.2017.07.003_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00044011-200222070-00002","article-title":"Effects of oral contraceptives on the pharmacokinetics of moxifloxacin in premenopausal women","volume":"22","author":"Shain","year":"2002","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ajog.2017.07.003_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/clpt.1990.92","article-title":"A\u00a0model to detect interactions between roxithromycin and oral contraceptives","volume":"47","author":"Meyer","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2017.07.003_bib31","first-page":"81","article-title":"The interaction between clarithromycin and combined oral-contraceptive steroids","volume":"1","author":"Back","year":"1991","journal-title":"J\u00a0Pharm Med"},{"key":"10.1016\/j.ajog.2017.07.003_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0029-7844(95)00075-3","article-title":"Dirithromycin increases ethinyl estradiol clearance without allowing ovulation","volume":"86","author":"Wermeling","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.07.003_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2012.01.010","article-title":"Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women","volume":"86","author":"Blode","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.00717-11","article-title":"Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age","volume":"56","author":"Fischer","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2017.07.003_bib35","first-page":"191","article-title":"Norethisterone and ethinyl estradiol kinetics during dapsone therapy","volume":"32","author":"Joshi","year":"1984","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.ajog.2017.07.003_bib36","first-page":"1782","article-title":"Compatibility of oral contraceptive with anti-tubercular chemotherapy in female pulmonary tuberculosis patients","volume":"62","author":"Mehrotra","year":"1974","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ajog.2017.07.003_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jcpt.12098","article-title":"Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate","volume":"38","author":"Pohl","year":"2013","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.ajog.2017.07.003_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-200544040-00007","article-title":"Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomized trials","volume":"44","author":"Dogterom","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2017.07.003_bib39","series-title":"Clinical gynecologic endocrinology and infertility","author":"Fritz","year":"2011"},{"key":"10.1016\/j.ajog.2017.07.003_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib41","doi-asserted-by":"crossref","first-page":"880","DOI":"10.14219\/jada.archive.2002.0302","article-title":"Antibiotic interference with oral contraceptives","volume":"133","year":"2002","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.ajog.2017.07.003_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.contraception.2016.03.010","article-title":"The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy","volume":"94","author":"Cherala","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib43","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2010.04.016","article-title":"Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review","volume":"82","author":"Edelman","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00003088-199936050-00001","article-title":"Interactions between oral contraceptives and antifungals\/antibacterials. Is contraceptive failure the result?","volume":"36","author":"Weisberg","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2017.07.003_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","article-title":"Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins","volume":"78","author":"Goldzieher","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.07.003_bib46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bdj.2012.414","article-title":"Antibiotics and oral contraceptives: new considerations for dental practice","volume":"212","author":"Taylor","year":"2012","journal-title":"Br Dent J"},{"key":"10.1016\/j.ajog.2017.07.003_bib47","unstructured":"Hormonal agents: Recommendations: American Academy of Dermatology Association. Available at: https:\/\/www.aad.org\/practicecenter\/quality\/clinical-guidelines\/acne\/hormonal-agents. Accessed June 13,\u00a02017."}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817308451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817308451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:18:34Z","timestamp":1757589514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817308451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0002937817308451"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.07.003","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug interactions between non-rifamycin antibiotics and hormonal contraception: a\u00a0systematic review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}